The pathogenesis of psoriasis has not yet been fully assessed, nevertheless there is understood to be an overwhelming influence of immunologic-genetic factors.
Some of the developments in the realm of psoriasis treatment are listed below-
More research is being carried out on antisense oligonucleotides.which has the potency to provide new therapeutic modalities for treating psoriasis.
ABT-874 , a new monoclonal antibody being developed by Abbott laboratories, has the potential to treat psoriasis
It has been clinically proven by Tas and Avci that cyclopamine has a better potential to treat psoriasis than some of the popularly used drugs.
Due to its anti-inflammatory properties,cannabis is being considered for psoriasis treatment